Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRenJi Hospital
About this trial
This study aims to establish an ambispective cohort platform centered on the pathological axis of "sarcopenia-metabolic disorders-aging progression", integrating multimodal data including demographic characteristics, lifestyle factors, clinical phenotypes, laboratory tests, medical imaging, and biospecimens. Namely 'Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)'.
Eligibility criteria
Qualifiers
None
Disqualifiers
Does not cooperate in signing the informed consent form;
Does not possess legal capacity;
In a state of loss of consciousness;
Suffering from severe mental illness, unable to communicate normally;
Trial design
Treatments tested in this trial
- nothing
Treatment groups
No treatment groups listed
Locations
1Department of Geriatrics, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China. Shanghai China
Sponsors and collaborators
RenJi Hospital
Lead sponsor
Source ClinicalTrials.gov